Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison between house dust mite sublingual immunotherapy and subcutaneous immunotherapy in maintenance-phase patients
TCTR20200606002Enrolling by invitation
- Sponsor
- Department of Medicine, Phramongkutklao Hospital
- Start
- Jun 2020
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Trial of House dust mite allergen extract in allergic rhinitis (AR) and allergic asthma (2 arms), sponsored by Department of Medicine, Phramongkutklao Hospital. Started Jun 2020; status: enrolling by invitation.
02
Drugs
House dust mite allergen extract
03
Conditions
allergic rhinitis (AR)allergic asthma
Beyond the preview
Go deeper on TCTR20200606002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200606002.